Search Results

There are 3736 results for: content related to: Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the I nternational C lub of A scites

  1. Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study

    Liver International

    Volume 33, Issue 8, September 2013, Pages: 1187–1193, Saubhik Ghosh, Narendra S. Choudhary, Arun K. Sharma, Baljinder Singh, Pradeep Kumar, Ritesh Agarwal, Navneet Sharma, Ashish Bhalla, Yogesh K. Chawla and Virendra Singh

    Version of Record online : 21 APR 2013, DOI: 10.1111/liv.12179

  2. You have free access to this content
    Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1153–1163, Søren Møller, Aleksander Krag and Flemming Bendtsen

    Version of Record online : 11 APR 2014, DOI: 10.1111/liv.12549

  3. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure

    Liver International

    Volume 36, Issue 1, January 2016, Pages: 59–67, Ankur Jindal, Ajeet S. Bhadoria, Rakhi Maiwall and Shiv K. Sarin

    Version of Record online : 18 SEP 2015, DOI: 10.1111/liv.12895

  4. You have free access to this content
    The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond

    Hepatology

    Volume 43, Issue 3, March 2006, Pages: 385–394, Richard Moreau and Didier Lebrec

    Version of Record online : 22 FEB 2006, DOI: 10.1002/hep.21094

  5. You have free access to this content
    Evolving concepts in primary sclerosing cholangitis

    Liver International

    Volume 32, Issue 3, March 2012, Pages: 352–369, Elisabeth Krones, Ivo Graziadei, Michael Trauner and Peter Fickert

    Version of Record online : 17 AUG 2011, DOI: 10.1111/j.1478-3231.2011.02607.x

  6. You have free access to this content
    Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome

    Hepatology

    Volume 51, Issue 1, January 2010, Pages: 219–226, André Nazar, Gustavo Henrique Pereira, Mónica Guevara, Marta Martín-Llahi, Marie-Noëlle Pepin, Marcella Marinelli, Elsa Solá, María Eugenia Baccaro, Carlos Terra, Vicente Arroyo and Pere Ginès

    Version of Record online : 9 SEP 2009, DOI: 10.1002/hep.23283

  7. Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndrome

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 10, October 2008, Pages: 1535–1540, Adam G Testro, Sarah Wongseelashote, Peter W Angus and Paul J Gow

    Version of Record online : 3 SEP 2007, DOI: 10.1111/j.1440-1746.2007.05176.x

  8. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: A retrospective analysis

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue 8, August 2002, Pages: 882–888, Isabelle Colle, François Durand, Fabienne Pessione, Emmanuel Rassiat, Jacques Bernuau, Eric Barrière, Didier Lebrec, Dominique-Charles Valla and Richard Moreau

    Version of Record online : 7 AUG 2002, DOI: 10.1046/j.1440-1746.2002.02816.x

  9. Herbal hepatotoxicity: a tabular compilation of reported cases

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1543–1556, Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze and Axel Eickhoff

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02864.x

  10. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-analysis of randomized controlled trials

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 880–885, Sashidhar V Sagi, Sahil Mittal, Krishna S Kasturi and Gagan K Sood

    Version of Record online : 14 JAN 2010, DOI: 10.1111/j.1440-1746.2009.06132.x

  11. You have free access to this content
    Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1133–1152, Gianluigi Mazzoccoli, Manlio Vinciguerra, Jude Oben, Roberto Tarquini and Salvatore De Cosmo

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12534

  12. You have free access to this content
    Hepatorenal syndrome, pharmacological therapy, and liver transplantation

    Liver Transplantation

    Volume 17, Issue 11, November 2011, Pages: 1244–1246, Pere Ginès

    Version of Record online : 26 OCT 2011, DOI: 10.1002/lt.22433

  13. You have free access to this content
    Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

    Liver International

    Volume 32, Issue 5, May 2012, Pages: 712–731, Marina Berenguer, Ramón Charco, Juan Manuel Pascasio and Jose Ignacio Herrero, on behalf of the Sociedad Española de Trasplante Hepático

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1478-3231.2011.02731.x

  14. You have free access to this content
    Terlipressin: An Asset for Hepatologists!

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 724–728, S.K. Sarin and Praveen Sharma

    Version of Record online : 25 JUL 2011, DOI: 10.1002/hep.24519

  15. You have free access to this content
    Liver tissue engineering and cell sources: issues and challenges

    Liver International

    Volume 33, Issue 5, May 2013, Pages: 666–676, Anwar A. Palakkan, David C. Hay, Anil K. PR, Kumary TV and James A. Ross

    Version of Record online : 15 MAR 2013, DOI: 10.1111/liv.12134

  16. You have free access to this content
    The nitric oxide pathway – evidence and mechanisms for protection against liver ischaemia reperfusion injury

    Liver International

    Volume 32, Issue 4, April 2012, Pages: 531–543, Mahmoud Abu-Amara, Shi Yu Yang, Alexander Seifalian, Brian Davidson and Barry Fuller

    Version of Record online : 8 FEB 2012, DOI: 10.1111/j.1478-3231.2012.02755.x

  17. A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 544–551, Karla C. L. Lee, Carolina Palacios Jimenez, Hatim Alibhai, Yu-Mei Chang, Pamela J. Leckie, Luisa A. Baker, Giacomo Stanzani, Simon L. Priestnall, Rajeshwar P. Mookerjee, Rajiv Jalan and Nathan A. Davies

    Version of Record online : 20 JAN 2013, DOI: 10.1111/liv.12042

  18. You have free access to this content
    Diabetes mellitus in patients with cirrhosis: clinical implications and management

    Liver International

    Volume 36, Issue 7, July 2016, Pages: 936–948, Laure Elkrief, Pierre-Emmanuel Rautou, Shiv Sarin, Dominique Valla, Valérie Paradis and Richard Moreau

    Version of Record online : 4 APR 2016, DOI: 10.1111/liv.13115

  19. You have free access to this content
    Antioxidants as therapeutic agents for liver disease

    Liver International

    Volume 31, Issue 10, November 2011, Pages: 1432–1448, Ashwani K. Singal, Sarat C. Jampana and Steven A. Weinman

    Version of Record online : 29 JUL 2011, DOI: 10.1111/j.1478-3231.2011.02604.x

  20. You have free access to this content
    Current treatment strategies for hepatorenal syndrome

    Clinical Liver Disease

    Volume 2, Issue 3, June 2013, Pages: 136–139, Elsa Solà, Mónica Guevara and Pere Ginès

    Version of Record online : 21 JUN 2013, DOI: 10.1002/cld.209